ID: ALA2381354

Max Phase: Preclinical

Molecular Formula: C17H16N4O

Molecular Weight: 292.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCc1cccc(-n2cc(C(=O)c3ccccc3N)nn2)c1

Standard InChI:  InChI=1S/C17H16N4O/c1-2-12-6-5-7-13(10-12)21-11-16(19-20-21)17(22)14-8-3-4-9-15(14)18/h3-11H,2,18H2,1H3

Standard InChI Key:  RXWSUUVVIOGKCA-UHFFFAOYSA-N

Associated Targets(Human)

Estrogen-related receptor alpha 573 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 292.34Molecular Weight (Monoisotopic): 292.1324AlogP: 2.64#Rotatable Bonds: 4
Polar Surface Area: 73.80Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 2.18CX LogP: 4.30CX LogD: 4.30
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.59Np Likeness Score: -1.59

References

1. Xu S, Zhuang X, Pan X, Zhang Z, Duan L, Liu Y, Zhang L, Ren X, Ding K, Ding K..  (2013)  1-Phenyl-4-benzoyl-1H-1,2,3-triazoles as orally bioavailable transcriptional function suppressors of estrogen-related receptor α.,  56  (11): [PMID:23656512] [10.1021/jm4003928]

Source